NCT02492750View on ClinicalTrials.gov

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 5, 2019

Study Completion Date

September 13, 2019

Conditions
Indolent Plasma Cell MyelomaPlasma Cell MyelomaSmoldering Plasma Cell Myeloma
Interventions
BIOLOGICAL

Anakinra

Given SC

DRUG

Dexamethasone

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Lenalidomide

Given PO

OTHER

Placebo

Given SC

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

collaborator

National Cancer Institute (NCI)

NIH